ASH Clinical News August 2015_updated | Page 51

DEEPER
RESPONSES?
LONGER DURATION
OF THERAPY?
It’s time to take a deeper look
at the critical debates in
multiple myeloma today.
SEE WHAT YOUR PEERS SAY AND SHARE YOUR OPINION AT
DEBATINGMYELOMA.COM

Takeda Oncology and
are registered trademarks of Takeda Pharmaceutical Company Limited.
Other trademarks are the property of their respective owners.
Copyright © 2015, Millennium Pharmaceuticals, Inc.

All rights reserved.

Printed in the USA

USO/NON/15/0122

4/15